Irish Life Investment Managers’s Accretive Health AH Stock Holding History

Irish Life Investment Managers’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$10.1K	Buy	+936	New	+$9.85K	﹤0.01%	1936

Other funds holding AH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JRP

Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

NRC

North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Sageview Capital Greenwich, Connecticut $177M AUM 36.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Irish Life Investment Managers's AH Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Accretive Health (AH) in Q2 2013: 936 shares worth $10.1K. The stake represents ﹤0.01% of the portfolio and ranks #1936 among its holdings.

98 funds tracked by Wall St. Rank hold AH as of Q2 2013.

Irish Life Investment Managers held 936 shares of Accretive Health worth $10.1K as of Q2 2013.
Accretive Health was a new Irish Life Investment Managers position in Q2 2013.
Accretive Health made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1936 holding.
98 funds tracked by Wall St. Rank held Accretive Health as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.